Washington: The Food and Drug Administration (FDA) of the United States has allowed an emergency use of remdesivir, an Ebola drug, for the treatment of severely ill patients of coronavirus.
After the FDA authorisation, now the Ebola drug could be used for severely ill patients of Covid-19 only at hospitals.
Experts said that the use of drug had helped shorten the recovery time of serious patients during a recent clinical trial.
They, however, cleared that the drug did not significantly help improve the rate of survival.
The researchers warned that remdesivir, manufactured by Gilead pharmaceuticals, is not a magical bullet for the virus.
Meanwhile, the World Health Organization has said that the new coronavirus is natural in origin and did not originate in a Chinese lab.
Earlier, US President Donald Trump claimed to had seen evidence that the virus originated in a lab in China.
Meanwhile, the researchers said that the coronavirus had jumped to humans from animals in Wuhan wet market.
I have seen evidence that the virus originated in a Wuhan lab, the US president claimed on Thuraday. However, he refused to share further details in this regard.
“We have listened to several researchers who had closely monitor the sequences of coronavirus,” WHO emergencies chief Michael Ryan said during a virtual presser
